AFRM vs COLL
Affirm Holdings Inc (AFRM) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the AFRM and COLL stock pages for the full models.
Not investment advice.